A national analysis of complications following total hip replacement in patients with chronic obstructive pulmonary disease

Medicine (United States)

Volumn 95, Issue 12, 2016, Pages

  Liao, Kuang Ming ^a   Lu, Hsueh Yi ^b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL YUNLIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TAIWAN; TOTAL HIP PROSTHESIS; WOUND INFECTION; COMPLICATION; HIP REPLACEMENT; POSTOPERATIVE COMPLICATIONS;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES;

EID: 84962138845     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003182     Document Type: Article

References (37)

1. Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J. 2003;22(Suppl 46):64s-75s.
2. Jorgensen NR, Schwarz P. Osteoporosis in chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2008;14:84-92.
3. Gross NJ. Extrapulmonary effects of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2001;7:122-127.
4. Gan WZ, Man SFP, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59:574-580.
5. Gluck O, Colic G. Recognizing and treating glucocorticoid induced osteoporosis in patients with pulmonary disease. Chest. 2004;125:1859-1876.
6. Antonelli Incalzi R, Caradonna P, Ranieri P, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Resp Med. 2000;94:1079-1084.
7. Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285-289.
8. Anakwe RE, Middleton SD, Jenkins PJ, et al. Total hip replacement in patients with hip fracture: a matched cohort study. Trauma Acute Care Surg. 2012;73:738-742.
9. Arozullah AM, Khuri SF, Henderson WG, et al. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med. 2001;135:847-857.
10. Smetana GW. Preoperative pulmonary evaluation. N Engl J Med. 1999;340:937-944.
11. Trayner E Jr, Celli BR. Postoperative pulmonary complications. Med Clin North Am. 2001;85:1129-1139.
12. Wu CC, Hsu TW, Chang CM, et al. Age-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation. Medicine (Baltimore). 2015;94:e431.
13. Wolf BR, Lu X, Li Y, et al. Adverse outcomes in hip arthroplasty: long-term trends. J Bone Joint Surg Am. 2012;94:e103.
14. Kapoor A, Labonte AJ, Winter MR, et al. Risk of venous thromboembolism after total hip and knee replacement in older adults with comorbidity and co-occurring comorbidities in the Nationwide Inpatient Sample (2003-2006). BMC Geriatrics. 2010;10:63.
15. Berbari E, Hanssen A, Duffy M, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998;27:1247-1254.
16. Wilson M, Kelley K, Thornhill T. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am. 1990;72:878-883.
17. Zimmerli W. Infection and musculoskeletal conditions: prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol. 2006;20:1045-1063.
18. Schairer WW, Sing DC, Vail TP, et al. Causes and frequency of unplanned hospital readmission after total hip arthroplasty. Clin Orthop Relat Res. 2014;472:464-470.
19. Nazima A, Arpana V, Judith M, et al. Redefining readmission risk factors for general medicine patients. J Hosp Med. 2011;6:54-60.
20. Silverstein MD, Qin H. Risk factors for 30-day hospital readmission in patients >65 years of age. Proc (Bayl Univ Med Cent). 2008;21:363-372.
21. Lalmohamed A, Vestergaard P, Klop C, et al. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement. Arch Intern Med. 2012;172:1229-1235.
22. Klop C, de Vries F, Lalmohamed A, et al. Risk of myocardial infarction in Dutch patients following discharge for total hip/knee replacement and matched controls: a population-based cohort study. OA Epidemiol. 2013;1:6.
23. Hofmann S, Huemer G, Kratochwill C, et al. Pathophysiology of fat embolisms in orthopedics and traumatology. Orthopade. 1995;24: 84-93.
24. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002;39:542-553.
25. Lee WS, Kim KI, Lee HJ, et al. The incidence of pulmonary embolism and deep vein thrombosis after knee arthroplasty in Asians remains low: a meta-analysis. Clin Orthop Relat Res. 2013;471:1523-1532.
26. Restrepo MI, Mortensen EM, Pugh JA, et al. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J. 2006;28:346-351.
27. Collins R, Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988;318:1162-1173.
28. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386-1389.
29. Gunen H, Gulbas G, In E, et al. Venous thromboemboli and exacerbations of COPD. Eur Respir J. 2010;35:1243-1248.
30. Stein PD, Beemath A, Meyers FA, et al. Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease. J Cardiovasc Med (Hagerstown). 2007;8:253-257.
31. Tan KK, Koh WP, Chao AK. Risk factors and presentation of deep venous thrombosis among Asian patients: a hospital-based case-control study in Singapore. Ann Vasc Surg. 2007;21:490-495.
32. Jameson SS, Khan SK, Baker P, et al. A national analysis of complications following hemiarthroplasty for hip fracture in older patients Q J Med. 2012;105:455-460.
33. Koval KJ, Skovron ML, Aharonoff GB, et al. Predictors of functional recovery after hip fracture in the elderly. Clin Orthop Relat Res. 1998;348:22-28.
34. Parvizi J, Ereth MH, Lewallen DG. Thirty-day mortality following hip arthroplasty for acute fracture. J Bone Joint Surg. 2004;86:1983-1988.
35. Björkelund KB, Hommel A, Thorngren KG, et al. Factors at admission associated with 4 months outcome in elderly patients with hip fracture. AANA J. 2009;77:49-58.
36. Hindmarsh DM, Hayen A, Finch CF, et al. Relative survival after hospitalisation for hip fracture in older people in New South Wales, Australia. Osteoporos Int. 2009;20:221-229.
37. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2095-2128.